ArticleJournal of the American Academy of Dermatology2014
Guidelines of care for the management of atopic dermatitis: Section 4. Prevention of disease flares and use of adjunctive therapies and approaches.
2 registry-linked trialsOpen access · greenAbstract readConsensus Statement
In one paragraph
Article in Journal of the American Academy of Dermatology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 105 papers, 6 of them syntheses that pooled it.
0numbers the graph read from it
0cells of the map it votes in
105citing papers in PubMed, 6 pooled it
27.6field-weighted citation impact, top 1% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
A Multicentre Study Evaluating the Efficacy of Combining Topical Antibiotic/Steroid/Moisturizer Therapy Compared to Standard of Care in the Treatment of Severe Atopic Dermatitis, a Phase II Randomized, Clinical Trial
Efficacy of Fermented Rice Flour for the Treatment of Atopic Dermatitis : Randomized, Double-Blind, Placebo-Controlled Trial
Who cites it
105 citing papers in PubMed, 6 syntheses or guidelines pooled it, 317 citations in OpenAlex.
- Efficacy, Safety, Quality of Life, and Adherence of Dupilumab in Pediatric Atopic Dermatitis: A Systematic Review.Clinical drug investigation · 2026Pooled it
- The association between atopic dermatitis and linear growth in children- a systematic review.European journal of pediatrics · 2024Pooled it
- Treatment Guidelines for Atopic Dermatitis Since the Approval of Dupilumab: A Systematic Review and Quality Appraisal Using AGREE-II.Frontiers in medicine · 2022Pooled it
- Pooled it
- Systematic Review on the Efficacy and Safety of Oral Janus Kinase Inhibitors for the Treatment of Atopic Dermatitis.Frontiers in medicine · 2021Pooled it
- Emollients and moisturisers for eczema.The Cochrane database of systematic reviews · 2017Pooled it
- Integrated Efficacy and Safety Analysis of Abrocitinib in Adolescents With Moderate-to-Severe Atopic Dermatitis.Allergy · 2025Trial
- Eczema Care Online behavioural interventions to support self-care for children and young people: two independent, pragmatic, randomised controlled trials.BMJ (Clinical research ed.) · 2022Trial
- Efficacy and safety of topical brepocitinib for the treatment of mild-to-moderate atopic dermatitis: a phase IIb, randomized, double-blind, vehicle-controlled, dose-ranging and parallel-group study.The British journal of dermatology · 2022Trial
- Remote Interdisciplinary Care for Atopic Dermatitis Using a Digital Care Concept (ADCompanion): Protocol for a Multicenter Randomized Trial.JMIR research protocols · 2026Article
- Efficacy and Safety of Variable-Dose Versus Continuous-Dose Abrocitinib Treatment in Patients with Moderate-to-Severe Atopic Dermatitis: A Pooled Analysis.Dermatology and therapy · 2026Article
- Calcineurin Inhibitors in Atopic Dermatitis: Balancing Tradition with Emerging Therapeutics.Medical sciences (Basel, Switzerland) · 2026Review
- Hypogammaglobulinemia in Children with Atopic Dermatitis.Children (Basel, Switzerland) · 2026Article
- Safety and efficacy of dupilumab in adult atopic dermatitis in Singapore.Singapore medical journal · 2026Article
- Alopecia Areata and Atopic Dermatitis: Common Mechanisms and Emerging Therapeutics.Journal of inflammation research · 2026Review
- Patient and Caregiver Perceptions on Education and Treatment Needs in Atopic Dermatitis from an International Survey.Dermatology and therapy · 2026Article
- Discovery of a PDE4B and PDE4D selective bifunctional degrader for management of chronic inflammatory disorders.Journal of translational autoimmunity · 2025Article
- Gut mucosal immune responses - Implications for celiac disease and food allergy.Seminars in immunology · 2025Review
- From Pathways to Patients in Atopic Dermatitis: Advanced Systemic Therapies.International journal of molecular sciences · 2025Review
- Defining "Flares" in Atopic Dermatitis: A Narrative Review.American journal of clinical dermatology · 2025Review
45 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
23 authors at 17 institutions in 4 countries.
Robert SidburyDepartment of Dermatology, Seattle Children's Hospital, Seattle, Washington.
Wynnis L TomUniversity of California, San Diego and Division of Pediatric and Adolescent Dermatology, Rady Children's Hospital, San Diego, California.
James N BergmanDepartment of Dermatology and Skin Science, University of British Columbia, Vancouver, British Columbia, Canada.
Kevin D CooperDepartment of Dermatology, Case Western University, Cleveland, Ohio.
Robert A Silvermanprivate practice, Fairfax, Virginia.
Timothy G BergerDepartment of Dermatology, University of California San Francisco, San Francisco, California.
Sarah L ChamlinDepartment of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
David E CohenDepartment of Dermatology, New York University School of Medicine, New York, New York.
Kelly M CordoroDepartment of Dermatology, University of California San Francisco, San Francisco, California.
Dawn M DavisDepartment of Dermatology, Mayo Clinic, Rochester, Minnesota.
Steven R FeldmanDepartment of Dermatology, Wake Forest University Health Sciences, Winston-Salem, North Carolina.
Jon M HanifinDepartment of Dermatology, Oregon Health & Science University, Portland, Oregon.
Alfons KrolDepartment of Dermatology, Oregon Health & Science University, Portland, Oregon.
David J MargolisDepartment of Biostatistics and Epidemiology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania.
Amy S PallerDepartment of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
Kathryn SchwarzenbergerKaplan-Amonette Department of Dermatology, University of Tennessee Health Science Center, Memphis, Tennessee.
Eric L SimpsonDepartment of Dermatology, Oregon Health & Science University, Portland, Oregon.
Hywel C WilliamsCentre of Evidence-Based Dermatology, Nottingham University Hospitals National Health Service Trust, Nottingham, United Kingdom.
Craig A ElmetsDepartment of Dermatology, University of Alabama at Birmingham, Birmingham, Alabama.
Julie BlockNational Eczema Association, San Rafael, California.
Christopher G HarrodAmerican Academy of Dermatology, Schaumburg, Illinois.
Wendy Smith BegolkaAmerican Academy of Dermatology, Schaumburg, Illinois. Electronic address: wsmithbegolka@aad.org.
Lawrence F EichenfieldUniversity of California, San Diego and Division of Pediatric and Adolescent Dermatology, Rady Children's Hospital, San Diego, California.
Oregon Health & Science University · USAmerican Academy of Dermatology · USNorthwestern University · USUniversity of California, San Francisco · USCase Western Reserve University · USMayo Clinic · USNational Health Service · GBNew York University · USRady Children's Hospital-San Diego · USRafael Advanced Defense Systems (Israel) · ILSeattle Children's Hospital · USUniversity of Alabama at Birmingham · USUniversity of British Columbia · CAUniversity of California San Diego · USUniversity of Pennsylvania · USUniversity of Tennessee Health Science Center · USWake Forest University · US
Funding
Vitamin D endocrine system and Protection Against Skin TumorlgenesisP30AR039750 · NIAMS · CASE WESTERN RESERVE UNIVERSITY · PI COOPER, KEVIN D · 1988 to 2015
$9.1MGenetic Influence in Pediatric PsoriasisK23AR060274 · NIAMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI TOM, WYNNIS L · 2011 to 2015
$663kNIAMS NIH HHS K23 AR060274NIAMS NIH HHS P30 AR039750
Abstract
Atopic dermatitis is a common, chronic inflammatory dermatosis that can affect all age groups. This evidence-based guideline addresses important clinical questions that arise in its management. In this final section, treatments for flare prevention and adjunctive and complementary therapies and approaches are reviewed. Suggestions on use are given based on available evidence.
Indexed as
Evidence-Based MedicinePractice Guidelines as TopicDermatitis, AtopicDermatologic AgentsHumansHypersensitivityImmunosuppressive AgentsDermatologic AgentsImmunosuppressive Agentsaeroallergensallergy testingatopic dermatitiscalcineurin inhibitorscomplementary therapycorticosteroidsdieteducationflarefood allergytopicals
Identifiers
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390
Registered trials
NCT03052348ClinicalTrials.gov
NCT03157284ClinicalTrials.gov
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.